全文获取类型
收费全文 | 1502篇 |
免费 | 97篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 31篇 |
妇产科学 | 36篇 |
基础医学 | 170篇 |
口腔科学 | 33篇 |
临床医学 | 206篇 |
内科学 | 245篇 |
皮肤病学 | 24篇 |
神经病学 | 115篇 |
特种医学 | 95篇 |
外科学 | 232篇 |
综合类 | 27篇 |
一般理论 | 1篇 |
预防医学 | 93篇 |
眼科学 | 47篇 |
药学 | 150篇 |
中国医学 | 15篇 |
肿瘤学 | 70篇 |
出版年
2023年 | 20篇 |
2022年 | 37篇 |
2021年 | 76篇 |
2020年 | 53篇 |
2019年 | 82篇 |
2018年 | 79篇 |
2017年 | 58篇 |
2016年 | 61篇 |
2015年 | 51篇 |
2014年 | 63篇 |
2013年 | 114篇 |
2012年 | 110篇 |
2011年 | 120篇 |
2010年 | 82篇 |
2009年 | 75篇 |
2008年 | 82篇 |
2007年 | 52篇 |
2006年 | 52篇 |
2005年 | 44篇 |
2004年 | 45篇 |
2003年 | 44篇 |
2002年 | 39篇 |
2001年 | 26篇 |
2000年 | 18篇 |
1999年 | 7篇 |
1998年 | 7篇 |
1997年 | 4篇 |
1996年 | 3篇 |
1995年 | 9篇 |
1993年 | 2篇 |
1992年 | 6篇 |
1991年 | 4篇 |
1990年 | 3篇 |
1989年 | 8篇 |
1988年 | 12篇 |
1987年 | 7篇 |
1986年 | 6篇 |
1985年 | 8篇 |
1984年 | 3篇 |
1983年 | 6篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1979年 | 7篇 |
1978年 | 2篇 |
1975年 | 4篇 |
1974年 | 2篇 |
1969年 | 1篇 |
1968年 | 1篇 |
1967年 | 2篇 |
1966年 | 1篇 |
排序方式: 共有1606条查询结果,搜索用时 656 毫秒
41.
Ramezani A Velayati AA Eslamifar A Banifazl M Ahmadi F Maziar S Razeghi E Kalantar E Amirkhani A Aghakhani A 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2008,12(2):143-146
Although the efficacy of hepatitis B vaccines in patients undergoing chronic hemodialysis (HD) treatment has been documented, the persistence of immunity in this population remains largely unknown. In this study we evaluated the persistence of hepatitis B vaccine immunity in HD patients. We followed 37 hepatitis B vaccinated HD patients (following a four-dose vaccination schedule of 40 mug injections intramuscularly in the deltoid muscle at 0, 1, 2, and 6 months) for up to one year to evaluate the persistence of immunity (as indicated by serum levels of hepatitis B surface antibody (anti-HBs) equal to or higher than 10 IU/L). One year after vaccination, 18.9% of patients had lost their anti-HBs (transient responders), while 81.1% still had detectable antibodies in the serum (persistent responders). From 81.1% of persistent responders 11.5% and 88.5% were weak and high responders, respectively. There was no significant difference between persistent and transient responders regarding age, sex, or nutritional factors. We did not find any factors that related to maintaining protective levels of anti-HBs in HD patients. It seems that an antibody titer above 100 IU/L following vaccination is necessary in order to maintain that level of antibody one year later. 相似文献
42.
43.
44.
Vahid Farnia Jalal Shakeri Faezeh Tatari Toraj Ahmadi Juibari Katayoun Yazdchi Hafez Bajoghli 《The American journal of drug and alcohol abuse》2014,40(1):10-15
Background: Lifetime prevalence of amphetamine-induced psychotic disorder is reported as being up to 23% for methamphetamine (MA) abusers. Approximately 25% of those with a baseline DSM-IV diagnosis of substance-induced psychosis are diagnosed with primary psychosis at one-year follow-up. Evidence on the treatment of amphetamine psychosis is very limited. Objectives: To investigate the efficacy of risperidone versus aripiprazole in treatment of amphetamine-induced psychotic symptoms. Methods: In a double-blind study, 45 participants were randomly allocated to either aripiprazole 15?mg or risperidone 4?mg daily over a six-week trial. Positive and negative symptoms of psychosis were assessed using the Scale for Assessment of Negative Symptoms (SANS) and the Scale for Assessment of Positive Symptoms (SAPS) at baseline and completion of the trial. Results: SANS and SAPS scores decreased significantly in both groups. Mean SAPS score reduction in risperidone and aripiprazole group was 16.20 and 10.80, respectively, after trial course (p?0.001). Mean SANS score reduction in risperidone and aripiprazole group was 9.35 and 11.25, respectively (p?=?0.08). Conclusions: Both aripiprazole and risperidone were effective for patients diagnosed with amphetamine-induced psychotic disorder. However, risperidone had the greater effect on positive psychotic symptoms while patients with negative symptoms may respond better to aripiprazole. There is a case for further studies evaluating the efficacy of atypical antipsychotics in this disorder. 相似文献
45.
46.
Kochawan Boonyawat Pantep Angchaisuksiri Katcharin Aryurachai Suchart Chaiyaroj Zohra Ahmadi Beng Hock Chong 《Thrombosis research》2014
Introduction
Heparin induced-thrombocytopenia (HIT) has been well recognized in Western countries. However, there are no data in the Thai population. We therefore investigated the prevalence of anti-platelet factor 4 (PF4)/heparin antibodies, HIT, and its thrombotic complications in Thai patients undergoing cardiac surgery using unfractionated heparin.Materials and methods
Seventy-three consecutive patients were prospectively enrolled in this study. Blood samples before operation and week 1, week 2, and week 3 after operation were collected from each patient for HIT antibody screening by enzyme-linked immunosorbent assay using IgG antibody specific to the PF4/heparin complex. Positive samples were further analyzed by 14C-serotonin release assay. Complete blood count was performed daily during the first week, then weekly for 3 weeks.Results
No patient had detectable anti-PF4/heparin antibodies at baseline. Five patients sero-converted during the course of the study for anti-PF4/heparin IgG: 3 (4.1%) at week 1, 4 (5.5%) at week 2, and 5 (6.8%) at week 3 after surgery. However, none of these patients had anti-PF4/heparin antibodies that resulted in 14C-serotonin release to be considered clinically significant antibodies. Post-operative thrombocytopenia after the operation was found in 35 patients (47.9%), but was not considered to be caused by HIT. Thromboembolic events occurred in 3 patients (4.1%) during follow up; however, none of these patients had positive PF4/heparin antibody tests.Conclusions
Our study represents the first study to examine Thai patients exposed to heparin in the context of cardiac surgery. We found a lower prevalence of positive anti-PF4/heparin antibodies and clinical HIT than previously published studies. 相似文献47.
48.
49.
Nader Maroufi Amir Ahmadi Seyedeh Roghayeh Mousavi Khatir 《European spine journal》2013,22(1):162-168
Purpose
The cervical flexion relaxation phenomenon (FRP) is a neck extensor myoelectric “silence” that occurs during complete cervical and lumbar flexion. In contrast to low back pain, the changes that occur during FRP in chronic neck pain (CNP) patients are still not clear. The aim of this study was to assess the characteristics of this phenomenon in the cervical region in CNP patients and controls.Methods
Twenty-two women (23 ± 2.62 years) with chronic non-specific neck pain and 21 healthy women (23.4 ± 1.68 years) participated in this study. They accomplished a cervical flexion and extension from neutral position. Neck angle and surface electromyographic activity of cervical erector spinae (CES) and upper trapezius muscles were recorded. Appearance, onset and offset angle of the FRP were analysed and compared between the two groups.Results
There were significant differences in the appearance of FRP between the two groups (P ≤ 0.001). The FRP in the CES muscles was observed in 85.7 % of healthy subjects and in 36.3 % of CNP patients, and no FRP was observed in the upper trapezius. Results of this study show that the onset and offset of FRP parameters were significantly different between the two groups (P ≤ 0.001).Conclusions
The results of the present study indicate that FRP in CNP patients was seen less than the healthy subjects, and moreover the FRP period was reduced in CNP patients. Our results also suggest that the changes in FRP of CNP patients may be due to the increased CES activity in these patients. 相似文献50.